Form D · Biotechnology
Cypris Medical, Inc.
Chicago, IL · CIK 0001667655
Offering snapshot reported Jun 30, 2020 · SEC filing
- Reported sold
- $150K Offering amount: $150K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jun 16, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2020 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Feb 25, 2019 | Amendment | $817,337 | $19,495vs Jan 22, 2019 | 25 | SEC filing |
| Jan 22, 2019 | Amendment | $797,842 | $205,460vs Sep 26, 2018 | 18 | SEC filing |
| Sep 26, 2018 | Amendment | $592,382 | $362,428vs Feb 23, 2018 | 18 | SEC filing |
| Feb 23, 2018 | Initial | $229,954 | No comparison | 7 | SEC filing |
| Sep 7, 2017 | Amendment | $755,000 | $458,000vs Jun 5, 2017 | 1 | SEC filing |
| Jun 5, 2017 | Amendment | $297,000 | $222,000vs Aug 25, 2016 | 1 | SEC filing |
| Aug 25, 2016 | Amendment | $75,000 | $0vs Mar 8, 2016 | 1 | SEC filing |
| Aug 25, 2016 | Amendment | $75,000 | $0vs Mar 8, 2016 | 1 | SEC filing |
| Mar 8, 2016 | Initial | $75,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369974
Source: Form D, filed Jun 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Louis Bucky | Director |
| Christopher Godek | Director |
| Daniel Holton | Director, Executive |
| Roger Holton | Director |
| Grant Stevens | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4541 N Ravenswood Suite 106
Chicago, IL, 60640
Chicago, IL, 60640